Published: 5/28/2021 9:50:19 AM
Respiratorius Q1 Review - Redeye
Redeye leaves a comment on Respiratorius following the release of the company’s report for the first quarter. We reiterate our Base case of SEK 2,8 and retain our positive stance on the company.
Read more about Respiratorius AB
Link to the analysis